CAMBRIDGE, Mass., Nov. 12, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc. (Nasdaq:LPTX), a company developing novel…
BOSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein…
DUBLIN and STAMFORD, Conn. and NEW YORK, Nov. 10, 2025 /PRNewswire/ -- Phoenix Aviation Capital ("Phoenix" or "the Company"), a…
Backed by iconic LPs across sports, media, and entertainment, 359 Capital will operate as a fully independent firm focused on…
November 08, 2025 17:13 ET | Source: Intellia Therapeutics, Inc. Deep, stable and durable reductions in kallikrein observed Among 32 patients…
VICTORIA, Seychelles, Nov. 4, 2025 /PRNewswire/ -- Bitget, the world's largest Universal Exchange (UEX), today announced a new Institutional Financing Program…
November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response is based on the Phase 3 DRAGON interim…
Grand Venture Technology embarks on the next chapter of global growth as Aalberts completes the privatisation of the company SINGAPORE,…
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics…
October 30, 2025 18:30 ET | Source: Bright Minds Biosciences NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bright Minds…